As of November 6, 2026, GRAIL, Inc. is a publicly traded company (Nasdaq: GRAL); its largest reported holder is Baker Bros. Advisors LP, with 9.8% on Schedule 13G/A of May 15, 2026, then Farallon Capital Management, L.L.C. (9.6%). The largest insider holding is Illumina, Inc., a 10% owner, with 3,502,126 shares (7.8% of shares outstanding), per Form 4 of November 18, 2025 (Schedule 13G/A, May 15, 2026).
Is this your company?
About to sign with, pay or invest in GRAIL, Inc.? See the free Snapshot first.
Free to see. No signup.
Is GRAIL, Inc. a real, registered company?
- GRAIL, Inc. files with the SEC under CIK 1699031 (its SEC filings).
- Its shares are listed under the ticker GRAL on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Sunnyvale, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under GRAIL, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Farallon Capital Management, L.L.C. (filed 2026-08-13).
Who are GRAIL, Inc.'s owners and officers?
GRAIL, Inc.: incorporated in Delaware; business address in Sunnyvale, California; industry Services-Medical Laboratories (Schedule 13G/A, 2026-11-05).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-11-07)
- : Director (Form D, 2025-11-07)
- : Director (Form D, 2025-11-07)
- : Director (Form D, 2025-11-07)
- : Director (Form D, 2025-11-07)
- : Executive Officer (Form D, 2025-11-07)
- : Executive Officer (Form D, 2025-11-07)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-05 | Primecap Management Co/Ca/ | 4.97% |
| Schedule 13G/A, 2026-08-13 | Farallon Capital Management, L.L.C. | 9.6% |
| Schedule 13G, 2026-08-07 | State Street Corporation | 5.6% |
| Schedule 13G/A, 2026-08-06 | Primecap Management Co/Ca/ | 5.08% |
| Schedule 13G/A, 2026-07-28 | Blackrock, Inc. | 7.9% |
| Schedule 13G/A, 2026-05-15 | Baker Bros. Advisors LP | 9.8% |
| Schedule 13G/A, 2026-05-11 | Dapice Joshua J. | 7.8% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G, 2026-02-17 | Baker Bros. Advisors LP | 5.3% |
| Schedule 13G/A, 2026-02-17 | Illumina, Inc. | 3.2% |
| Schedule 13G/A, 2026-02-11 | Primecap Management Co/Ca/ | 4.72% |
| Schedule 13G/A, 2026-02-09 | Dapice Joshua J. | 5.9% |
Questions about who owns GRAIL, Inc.
Who owns GRAIL, Inc.?
On this page, 5 holders' latest ownership filings report 5% or more of GRAIL, Inc.: Baker Bros. Advisors LP (9.8%, Schedule 13G/A, filed 2026-05-15), Farallon Capital Management, L.L.C. (9.6%, Schedule 13G/A, filed 2026-08-13), Blackrock, Inc. (7.9%, Schedule 13G/A, filed 2026-07-28), Dapice Joshua J. (7.8%, Schedule 13G/A, filed 2026-05-11) and State Street Corporation (5.6%, Schedule 13G, filed 2026-08-07).
Who are the largest shareholders of GRAIL, Inc.?
By the share each holder's latest filing reports, the largest holders of GRAIL, Inc. on this page are Baker Bros. Advisors LP (9.8%), Farallon Capital Management, L.L.C. (9.6%) and Blackrock, Inc. (7.9%).
When did Baker Bros. Advisors LP buy into GRAIL, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Baker Bros. Advisors LP on this page is the Schedule 13G, filed 2026-02-17, reporting 5.3%; its latest, Schedule 13G/A filed 2026-05-15, reports 9.8%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on GRAIL, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on GRAIL, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GRAIL, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own GRAIL, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Illumina, Inc., a 10% owner: 3,502,126 shares (7.8% of shares outstanding) (Form 4, 2025-11-18).
- , a 10% owner: 3,305,055 shares (7.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes) (Form 4, 2025-07-03).
- , the chief executive and a director: 518,582 shares (1.2% of shares outstanding) (Form 4, 2026-04-09).
- , the chief executive and a director: 342,271 shares (0.76% of shares outstanding) (Form 4, 2026-10-16).
- , the chief financial officer: 225,364 shares (0.50% of shares outstanding) (Form 4, 2026-10-07).
Shares outstanding: 44,962,171 as of 2026-11-02, from the company's latest SEC cover page.
How much has GRAIL, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-11-07 | $325M | $325M |
Keep reading
More on GRAIL, Inc. and the records around it.
GRAIL, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Form D filing Nov 2025
Companies that share a holder
- CRCM LP also filed stake reports on 2 other companies: AI Financial Corp (Aug 2026), Burning Rock Biotech Ltd. (May 2026)
- Farallon Capital Management, L.L.C. also filed stake reports on 18 other companies: EXELIXIS, INC. (Nov 2026), ENANTA PHARMACEUTICALS INC (Aug 2026), InflaRx N.V. (Aug 2026)
- Farallon Capital Partners, L.P. also filed stake reports on 19 other companies: BridgeBio Pharma, Inc. (May 2026), InflaRx N.V. (May 2026), Beta Bionics, Inc. (May 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/grail